logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Hormone replacement therapy and the risk of breast lesions that predispose to cancer.

    Article, Communication - En anglais

    Annual Meeting of the Southern California Chapter, American College of Surgeons. Dana Point (USA), 1997/01/17.

    To determine whether postmenopausal individuals being treated with hormone replacement therapy (HRT) have an increased risk for lesions that predispose to breast cancer, 156 women with benign breast lesions were retrospectively studied.

    Their ages ranged from 43 to 88.

    Each patient underwent a breast biopsy from 1991 to 1995.

    It was determined from chart review whether each of these patients had been treated with HRT.

    Fifty-seven of these patients had a biopsy finding that predisposed the patient to future breast cancer.

    The predisposing lesions included sclerosing adenosis, intraductal papilloma, and epithelial hyperplasia with atypia.

    Of these 57 patients, 36 (63%) were being treated with HRT.

    Only 30 of the 99 patients (30%) with nonproliferative lesions were treated with HRT (odds ratio, 3.9 ; P<0.0005).

    On the basis of the results of this study, we believe that the use of HRT may promote lesions that predispose to cancer.

    This suggests that patients treated with HRT require vigilant surveillance by way of examination and mammography.

    Mots-clés Pascal : Glande mammaire, Tumeur bénigne, Rétrospective, Hormone, Traitement substitutif, Facteur risque, Prédisposition, Postménopause, Evaluation, Biopsie, Femelle, Homme, Mammographie, Glande mammaire pathologie, Hormone stéroïde, Organisation santé, Radiodiagnostic

    Mots-clés Pascal anglais : Mammary gland, Benign neoplasm, Retrospective, Hormone, Replacement therapy, Risk factor, Predisposition, Postmenopause, Evaluation, Biopsy, Female, Human, Mammography, Mammary gland diseases, Steroid hormone, Public health organization, Radiodiagnosis

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0543276

    Code Inist : 002B02O. Création : 24/03/1998.